These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

312 related items for PubMed ID: 19464287

  • 1. Tormentic acid reduces vascular smooth muscle cell proliferation and survival.
    Fogo AS, Antonioli E, Calixto JB, Campos AH.
    Eur J Pharmacol; 2009 Aug 01; 615(1-3):50-4. PubMed ID: 19464287
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Valproic acid inhibits proliferation of human coronary vascular cells (SI/MPL-ratio: 0.5): a novel candidate for systemic and local therapy of postinterventional restenosis.
    Voisard R, Krebs R, Baur R, Hombach V.
    Coron Artery Dis; 2010 Aug 01; 21(5):286-91. PubMed ID: 20508518
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Dehydroleucodine inhibits vascular smooth muscle cell proliferation in G2 phase.
    Cruzado M, Castro C, Fernandez D, Gomez L, Roque M, Giordano OE, Lopez LA.
    Cell Mol Biol (Noisy-le-grand); 2005 Nov 08; 51(6):525-30. PubMed ID: 16309576
    [Abstract] [Full Text] [Related]

  • 6. Raphanus sativus and its isothiocyanates inhibit vascular smooth muscle cells proliferation and induce G(1) cell cycle arrest.
    Suh SJ, Moon SK, Kim CH.
    Int Immunopharmacol; 2006 May 08; 6(5):854-61. PubMed ID: 16546717
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Emodin induces growth arrest and death of human vascular smooth muscle cells through reactive oxygen species and p53.
    Wang X, Zou Y, Sun A, Xu D, Niu Y, Wang S, Wang K, Ge J.
    J Cardiovasc Pharmacol; 2007 May 08; 49(5):253-60. PubMed ID: 17513942
    [Abstract] [Full Text] [Related]

  • 10. A novel butyrolactone derivative inhibited smooth muscle cell migration and proliferation and maintained endothelial cell functions through selectively affecting Na, K-ATPase activity and mitochondria membrane potential during in vitro angiogenesis.
    Meng N, Zhao J, Zhao B, Cheng Y, Wang W, Zhang Y, Zhang S, Miao J.
    J Cell Biochem; 2008 Aug 15; 104(6):2123-30. PubMed ID: 18393353
    [Abstract] [Full Text] [Related]

  • 11. Comparative characterization of cellular and molecular anti-restenotic profiles of paclitaxel and sirolimus. Implications for local drug delivery.
    Wessely R, Blaich B, Belaiba RS, Merl S, Görlach A, Kastrati A, Schömig A.
    Thromb Haemost; 2007 Jun 15; 97(6):1003-12. PubMed ID: 17549304
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. 11,13-dihydro-dehydroleucodine, a derivative of dehydroleucodine with an inactivated alkylating function conserves the anti-proliferative activity in G2 but does not cause cytotoxicity.
    Polo LM, Castro CM, Cruzado MC, Collino CJ, Cuello-Carrión FD, Ciocca DR, Giordano OS, Ferrari M, López LA.
    Eur J Pharmacol; 2007 Feb 05; 556(1-3):19-26. PubMed ID: 17134695
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Perivascular adipose tissue-derived visfatin is a vascular smooth muscle cell growth factor: role of nicotinamide mononucleotide.
    Wang P, Xu TY, Guan YF, Su DF, Fan GR, Miao CY.
    Cardiovasc Res; 2009 Feb 01; 81(2):370-80. PubMed ID: 18952695
    [Abstract] [Full Text] [Related]

  • 18. Platelet-derived growth factor receptor antagonist STI571 (imatinib mesylate) inhibits human vascular smooth muscle proliferation and migration in vitro but not in vivo.
    Hacker TA, Griffin MO, Guttormsen B, Stoker S, Wolff MR.
    J Invasive Cardiol; 2007 Jun 01; 19(6):269-74. PubMed ID: 17541129
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.